Comparative study of the inhibition of metallo-β-lactamases (IMP-1 and VIM-2) by thiol compounds that contain a hydrophobic group

被引:23
作者
Jin, WC
Arakawa, Y
Yasuzawa, H
Taki, T
Hashiguchi, R
Mitsutani, K
Shoga, A
Yamaguchi, Y
Kurosaki, H
Shibata, N
Ohta, M
Goto, M
机构
[1] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan
[2] Natl Inst Infect Dis, Dept Bacterial Pathogenesis & Infect Control, Tokyo 2080011, Japan
[3] Nagoya Univ, Sch Med, Dept Bacteriol, Nagoya, Aichi 4668550, Japan
关键词
metallo-beta-lactamase; inhibitor; thiol; zinc; 3-mercaptopropionic acid;
D O I
10.1248/bpb.27.851
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
For the purpose of screening of inhibitors that are effective for wide range of metallo-beta-lactamases, the inhibitory effect of two series of compounds, 2-omega-phenylalkyl-3-mercaptopropionic acid (PhenylCnSH (n=1-4)) and N-[(7-chloro-quinolin-4-ylamino)-alkyll-3-mercapto-propionamide (QuinolineCnSH (n=2-6)), where n denotes the alkyl chain length, on metallo-beta-lactamases IMP-1 and VIM-2 was examined. These inhibitors contain a thiol group and a hydrophobic group linked by variable-length methylene chain. PhenylCnSH (n=1-4) was found to be a potent inhibitor of both IMP-1 and VIM-2. PhenylC4SH was the potent inhibitor of both IMP-1 (IC50= 1.2 mum) and VIM-2 (IC50= 1.1 mum) among this study. When the number of methylene units was varied, QuinolineC4SH showed the maximum inhibitory activity against IMP-1 and VIM-2 (IC50=2.5mum and IC50=2.4mum). The relationship between the inhibitory effect of the alkyl chain length was different for both series of inhibitors, suggesting that IMP-1 has a tighter binding site than VIM-2. QuinolineCnSH did not serve as a fluorescence reagent for metallo-beta-lactamases.
引用
收藏
页码:851 / 856
页数:6
相关论文
共 45 条
[2]
Arakawa Y, 2000, J CLIN MICROBIOL, V38, P40
[3]
A NOVEL INTEGRON-LIKE ELEMENT CARRYING THE METALLO-BETA-LACTAMASE GENE BLA(IMP) [J].
ARAKAWA, Y ;
MURAKAMI, M ;
SUZUKI, K ;
ITO, H ;
WACHAROTAYANKUN, R ;
OHSUKA, S ;
KATO, N ;
OHTA, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) :1612-1615
[4]
Cysteinyl peptide inhibitors of Bacillus cereus zinc β-lactamase [J].
Bounaga, S ;
Galleni, M ;
Laws, AP ;
Page, MI .
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (02) :503-510
[5]
The mechanism of catalysis and the inhibition of the Bacillus cereus zinc-dependent β-lactamase [J].
Bounaga, S ;
Laws, AP ;
Galleni, M ;
Page, MI .
BIOCHEMICAL JOURNAL, 1998, 331 :703-711
[6]
X-ray structure of the ZnII β-Lactamase from Bacteroides fragilis in an orthorhombic crystal form [J].
Carfi, A ;
Duee, E ;
Paul-Soto, R ;
Galleni, M ;
Frere, JM ;
Dideberg, O .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 1998, 54 :47-57
[7]
Crystal structure of the wide-spectrum binuclear zinc beta-lactamase from Bacteroides fragilis [J].
Concha, NO ;
Rasmussen, BA ;
Bush, K ;
Herzberg, O .
STRUCTURE, 1996, 4 (07) :823-836
[8]
Crystal structure of the IMP-1 metallo β-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor:: Binding determinants of a potent, broad-spectrum inhibitor [J].
Concha, NO ;
Janson, CA ;
Rowling, P ;
Pearson, S ;
Cheever, CA ;
Clarke, BP ;
Lewis, C ;
Galleni, M ;
Frère, JM ;
Payne, DJ ;
Bateson, JH ;
Abdel-Meguid, SS .
BIOCHEMISTRY, 2000, 39 (15) :4288-4298
[9]
Cricco JA, 1999, CURR PHARM DESIGN, V5, P915
[10]
Unanticipated inhibition of the metallo-β-lactamase from Bacteroides fragilis by 4-morpholineethanesulfonic acid (MES):: A crystallographic study at 1.85-Å resolution [J].
Fitzgerald, PMD ;
Wu, JK ;
Toney, JH .
BIOCHEMISTRY, 1998, 37 (19) :6791-6800